CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2024	Jun. 30, 2023
Current assets
Cash and cash equivalents	$ 202	$ 367
Receivables, net	695	688
Inventories, net	637	696
Prepaid expenses and other current assets	88	77
Total current assets	1,622	1,828
Property, plant and equipment, net	1,315	1,345
Operating lease right-of-use assets	360	346
Goodwill	1,228	1,252
Trademarks, net	538	543
Other intangible assets, net	143	169
Other assets	545	462
Total assets	5,751	5,945
Current liabilities
Notes and loans payable	4	50
Current operating lease liabilities	84	87
Accounts payable and accrued liabilities	1,486	1,659
Income taxes payable	0	121
Total current liabilities	1,574	1,917
Long-term debt	2,481	2,477
Long-term operating lease liabilities	334	310
Other liabilities	848	825
Deferred income taxes	22	28
Total liabilities	5,259	5,557
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2024 and 2023; and 124,201,807 and 123,820,022 shares outstanding as of June 30, 2024 and 2023, respectively	131	131
Additional paid-in capital	1,288	1,245
Retained earnings	250	583
Treasury stock, at cost: 6,539,654 and 6,921,439 shares as of June 30, 2024 and 2023, respectively	(1,186)	(1,246)
Accumulated other comprehensive net (loss) income	(155)	(493)
Total Clorox stockholders’ equity	328	220
Noncontrolling interests	164	168
Total stockholders’ equity	492	388
Total liabilities and stockholders’ equity	$ 5,751	$ 5,945